Milestone Pharmaceuticals (MIST) Prepaid Assets (2018 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Prepaid Assets came in at $1.2 million in Q1 2026, down 48.64% YoY from $2.4 million in Q1 2025, and down 32.96% on a QoQ basis from $1.8 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Prepaid Assets (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 9 years of Prepaid Assets data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Prepaid Assets fell 48.64% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 48.64% YoY) and the FY2025 annual result came in at $1.8 million, down 1.9% from the prior year.
- Prepaid Assets fell to $1.2 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.0 million in Q3 2023 to a low of $748000.0 in Q2 2025.
- A 5-year average of $3.3 million and a median of $2.6 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 55.84% — and 2024, when it slumped 68.28%.
- Tracing MIST's Prepaid Assets over 5 years: stood at $6.0 million in 2022, then plunged by 47.08% to $3.2 million in 2023, then sank by 42.1% to $1.8 million in 2024, then dropped by 1.9% to $1.8 million in 2025, then tumbled by 32.96% to $1.2 million in 2026.
- The last three Prepaid Assets figures came in at $1.2 million (Q1 2026), $1.8 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 748,000.00 |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 6.96 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 5.45 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Sep 30, 2022 | 5.06 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 4.07 Mn |
| Dec 31, 2021 | 4.30 Mn |
| Sep 30, 2021 | 5.97 Mn |